14 recruiting, 12 completed, 5 unknown, 3 active not recruiting. 27 Phase 1, 14 Phase 2, 1 Phase 3.
Follow Abbisko Therapeutics Co, Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of ABSK043 Combined With Osimertinib ABSK043 in combination with Osimertinib - Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive | Phase 2 | Not yet recruiting | Abbisko Therapeutics Co, Ltd | 72 | 2026-08-31 | 2026-07-17 |
| A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration ABSK211 - Solid Tumor (Phase I) | Phase 1 | Recruiting | Abbisko Therapeutics Co, Ltd | 247 | 2026-08-28 | 2026-09-04 |
| A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole Enteric-Coated Tablets on the Pharmacokinetics of ABSK-011 Capsules in Healthy Participants ABSK-011 Capsules, omeprazole enteric-coated tablets - Healthy Participants | Phase 1 | Recruiting | Abbisko Therapeutics Co, Ltd | 30 | 2026-07-21 | 2026-07-27 |
| A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma irpagratinib - Carcinoma, Hepatocellular | Phase 2 | Recruiting | Asan Medical Center | 33 | 2026-03-16 | 2026-07-15 |
| A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 ) ABSK141-400mg, ABSK141-Recommended Dose for Expansion (RDE), ABSK141-800mg - Solid Tumors, Adult | Phase 1 / Phase 2 | Recruiting | Abbisko Therapeutics Co, Ltd | 401 | 2026-03-02 | 2026-03-11 |
| A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia ABSK061 - Achondroplasia | Phase 1 / Phase 2 | Not yet recruiting | Abbisko Therapeutics Co, Ltd | 110 | 2025-12-10 | 2025-12-22 |
| A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib ABSK043 in combination with Glecirasib - Non-Small Cell Lung Cancer | Phase 2 | Recruiting | Abbisko Therapeutics Co, Ltd | 86 | 2025-09-22 | 2026-06-17 |
| A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Proportions in Healthy Subjects pimicotinib capsules - Pharmacokinetics in Healthy Volunteers | Phase 1 | Completed | Abbisko Therapeutics Co, Ltd | 20 | 2025-09-12 | 2025-11-26 |
| A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors ABSK131 - Solid Tumors (Phase 1) | Phase 1 | Recruiting | Abbisko Therapeutics Co, Ltd | 266 | 2025-07-22 | 2025-12-17 |
| A Study in Children With Achondroplasia No Interventions, complete a natural history observation of ACH for at least 6 months and up to 2 years - Achondroplasia | Recruiting | Abbisko Therapeutics Co, Ltd | 260 | 2025-06-20 | 2025-12-24 | |
| ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression ABSK-011+BSC, Placebo+BSC - Hepatocellular Carcinoma (HCC) | Phase 2 | Recruiting | Abbisko Therapeutics Co, Ltd | 141 | 2025-06-13 | 2026-01-08 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants ABSK061 - Healthy | Phase 1 | Completed | Abbisko Therapeutics Co, Ltd | 42 | 2025-05-17 | 2026-06-29 |
| A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy Subjects pimicotinib capsules - Pharmacokinetics | Phase 1 | Completed | Abbisko Therapeutics Co, Ltd | 38 | 2025-05-13 | 2025-08-17 |
| A Study to Evaluate the Effect of a High-fat Meal on the Exposure of Pimicotinib Capsule in Healthy Subjects Pimicotinib capsule - Healthy Subjects | Phase 1 | Active not recruiting | Abbisko Therapeutics Co, Ltd | 16 | 2025-04-08 | 2025-04-20 |
| A Mass Balance Study of [14C]ABSK011 [14C]ABSK011 - Healthy Subjects | Phase 1 | Not yet recruiting | Abbisko Therapeutics Co, Ltd | 6 | 2025-04-07 | 2025-03-26 |
| A Study to Investigate The Effect of Pimicotinib on The Pharmacokinetics of Metformin, Fexofenadine and Rosuvastatin In Healthy Subjects pimicotinib capsules - Healthy Subjects | Phase 1 | Completed | Abbisko Therapeutics Co, Ltd | 39 | 2025-03-14 | 2025-06-26 |
| A Study to Evaluate the Relative Bioavailability of Two Different Pimicotinib Capsules in Healthy Subjects pimicotinib capsules - Pharmacokinetics | Phase 1 | Completed | Abbisko Therapeutics Co, Ltd | 26 | 2024-12-10 | 2025-02-17 |
| A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib ABSK043 in combination with Firmonertinib - Non-Small Cell Lung Cancer With EGFR Mutation | Phase 2 | Recruiting | Abbisko Therapeutics Co, Ltd | 54 | 2024-11-25 | 2024-12-12 |
| A Phase 2 Clinical Study of ABSK061 and ABSK043 ABSK061 + ABSK043, ABSK061+ABSK043 in combination with CAPOX - HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma | Phase 2 | Recruiting | Abbisko Therapeutics Co, Ltd | 202 | 2024-11-13 | 2024-11-19 |
| The Study to Assess the Pharmacokinetics of Pimicotinib in Subjects With Mild and Moderate Hepatic Impairment Relative to Subjects With Normal Hepatic Function Pimicotinib - Pharmacokinetics | Phase 1 | Completed | Abbisko Therapeutics Co, Ltd | 24 | 2024-09-20 | 2025-01-20 |
Showing 20 of 39. Sign in to see all of them.
Carcinoma, Hepatocellular (3) · Carcinoma, Non-Small-Cell Lung (3) · Carcinoma, Transitional Cell (3) · Neoplasms (3) · Achondroplasia (2) · Giant Cell Tumor of Tendon Sheath (2) · Synovitis, Pigmented Villonodular (1) · Triple Negative Breast Neoplasms (1)
AZD4547 (3) · toripalimab (3) · Bevacizumab (1) · Drugs, Investigational (1) · Gemcitabine (1) · Immune Checkpoint Inhibitors (1) · Itraconazole (1) · Omeprazole (1) · Rifampin (1) · mavorixafor (1) · osimertinib (1) · tislelizumab (1)
China (36) · United States (6) · Taiwan (2) · Australia (1) · Canada (1) · Italy (1) · Netherlands (1) · Poland (1) · South Korea (1) · Spain (1)
Xianjun Yu, Doctor (2) · Yanhua Ding, Doctor (2) · Yuan Lu (2) · Dingwei Ye, Professor (1) · J L Zheng, Director (1) · Jermaine Coward (1) · Jing Zhang (1) · Jing Zhang, Professor (1) · Kai Huang (1) · Liyan Miao, Professor (1) · Quankun Zhuang, Doctor (1) · Shuqi Zeng (1) · Siqing Fu, MD (1) · Tianshu Liu, Doctor (1) · Wei Zhao, Doctor (1)